Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Survey reveals deficiencies in management of cancer treatment-induced bone loss for women
March 2nd, 2006
A recent survey revealed deficiencies in management of cancer treatment-induced bone loss for women in England. According to an article in the British Journal of Cancer, "New therapeutic options in breast cancer have improved survival but consequently increase the relevance of late complications. Ovarian suppression/ablation and aromatase inhibitors (AI) in the adjuvant setting have improved outcome, but have clinically important adverse effects on bone health. However, investigation and management of cancer treatment-induced bone loss (CTIBL) is poorly defined with no national guidance." J.E. Lester and colleagues of Weston Park Hospital in...
Source: Women's Health Weekly (2006-03-02)
|
